Final Stretch: Heme/Onc Key Points
- Crack Medicine

- Jun 21
- 4 min read
TL;DR
Final Stretch: Heme/Onc Key Points for MRCP Part 1 distils the most repeatedly tested concepts—anaemia patterns, haematological malignancies, coagulation disorders, transfusion reactions, and oncology emergencies. Focus on pattern recognition, not memorisation. Mastering a small set of high-yield frameworks will score more marks than broad but shallow revision.
Why this matters
Haematology and oncology are consistently high-yield areas in MRCP Part 1, frequently appearing as data interpretation questions rather than straightforward recall. Candidates often lose marks not because they lack knowledge, but because they fail to recognise patterns quickly under time pressure.
In the final revision phase, efficiency matters. Rather than revisiting entire textbooks, you should consolidate core frameworks and repeatedly tested associations. If you need a broader roadmap, revisit the MRCP Part 1 overview and assess your readiness with Free MRCP MCQs.
Core sections
1. Anaemia: Start with MCV + Reticulocytes
Anaemia is one of the most frequently tested areas and is best approached systematically.
Type | Common Causes | Key Exam Clue |
Microcytic | Iron deficiency, thalassaemia, anaemia of chronic disease | Ferritin ↓ in IDA, ↑ in ACD |
Normocytic | Acute blood loss, haemolysis | Reticulocytes ↑ |
Macrocytic | B12/folate deficiency, alcohol | Hypersegmented neutrophils |
High-yield points:
Vitamin B12 deficiency → neurological involvement (posterior column signs)
Iron deficiency in older adults → investigate for gastrointestinal malignancy
Anaemia of chronic disease → normal/high ferritin with low transferrin
2. Haematological Malignancies: Recognise the Signature
You should be able to identify these instantly:
Chronic myeloid leukaemia (CML): t(9;22), basophilia
Chronic lymphocytic leukaemia (CLL): smudge cells, lymphocytosis
Acute myeloid leukaemia (AML): Auer rods, risk of DIC
Multiple myeloma: CRAB features (hypercalcaemia, renal impairment, anaemia, bone lesions)
Exam strategy: Link laboratory findings with clinical presentation rather than recalling isolated facts.
3. Coagulation Disorders: Pathways + Patterns
Understanding pathways simplifies interpretation.
PT prolonged: extrinsic pathway (Factor VII, liver disease)
aPTT prolonged: intrinsic pathway (haemophilia, heparin use)
Both prolonged: DIC or severe liver dysfunction
Must-know conditions:
Disseminated intravascular coagulation → ↑ PT/aPTT, ↓ platelets, ↑ D-dimer
Haemophilia A → Factor VIII deficiency
von Willebrand disease → most common inherited bleeding disorder
4. Transfusion Medicine: Classic Reactions
Often overlooked but highly testable.
Febrile non-haemolytic reaction → most common
Acute haemolytic reaction → ABO incompatibility
Transfusion-related acute lung injury (TRALI) → acute hypoxia within 6 hours
Exam clue: Fever + hypotension after transfusion = suspect haemolysis until proven otherwise.
5. Oncology Basics: High-Yield Concepts
Focus on mechanisms and emergencies.
Tumour markers → supportive, not diagnostic
Paraneoplastic syndromes → e.g., SIADH in lung cancer
Oncological emergencies:
Tumour lysis syndrome → hyperkalaemia, hyperuricaemia
Spinal cord compression → urgent steroids + MRI
6. Thrombosis & Anticoagulation
Increasingly relevant in MRCP questions.
Warfarin → monitor INR, multiple drug interactions
Direct oral anticoagulants → renal function dependent
Heparin-induced thrombocytopenia → thrombosis despite low platelets
7. Plasma Cell Disorders
Multiple myeloma → rouleaux formation, M protein
Waldenström macroglobulinaemia → hyperviscosity syndrome
MGUS → premalignant condition
8. Bone Marrow Failure Syndromes
Aplastic anaemia → pancytopenia, hypocellular marrow
Myelofibrosis → tear-drop cells, splenomegaly
9. Lymphoma vs Leukaemia
Lymphoma → primarily nodal disease
Leukaemia → bone marrow and peripheral blood involvement
Key distinction:
Hodgkin lymphoma → Reed–Sternberg cells
Non-Hodgkin lymphoma → more extranodal spread
10. Five Most Tested Subtopics (Quick Revision List)
Anaemia classification and interpretation
Leukaemia and lymphoma patterns
Coagulation pathways
Transfusion reactions
Oncological emergencies

Practical examples / mini-cases
MCQ: A 65-year-old man presents with fatigue and bone pain. Blood tests show Hb 9 g/dL, elevated calcium, and raised creatinine. Serum electrophoresis reveals a monoclonal spike.
Most likely diagnosis? Answer: Multiple myeloma
Explanation: The combination of CRAB features (hypercalcaemia, renal dysfunction, anaemia, bone pain) is highly characteristic. This is a classic MRCP pattern-recognition question.
Common pitfalls
Confusing iron deficiency anaemia with anaemia of chronic disease
Over-relying on tumour markers for diagnosis
Missing DIC in acute leukaemia presentations
Forgetting that HIT causes thrombosis despite thrombocytopenia
Ignoring transfusion reactions in acute deterioration
Practical study-tip checklist
Revise frameworks (e.g., MCV-based anaemia classification)
Practise timed questions using Start a mock test
Focus on repeated exam themes
Review incorrect questions daily
Avoid starting new topics in the final days
FAQs
1. How important is haematology in MRCP Part 1?
It forms a significant portion of the exam, often integrated with clinical scenarios and lab interpretation.
2. Should I memorise tumour markers?
Focus on key associations and limitations rather than memorising exhaustive lists.
3. What is the best last-week strategy?
Revise high-yield topics, practise MCQs, and consolidate weak areas rather than learning new material.
4. How do I approach coagulation questions?
Understand pathways and associate them with common conditions like haemophilia and DIC.
5. Are oncology emergencies commonly tested?
Yes—tumour lysis syndrome and spinal cord compression are frequently examined.
Ready to start?
In the final stretch, prioritise clarity and repetition over volume. Use the MRCP Part 1 overview to structure your revision, reinforce learning with Free MRCP MCQs, and simulate exam conditions with a Start a mock test.
For further consolidation, revisit related topics such as tumour markers and clinical triads to strengthen recall under exam conditions.
Sources
MRCP(UK) Examination Blueprint: https://www.mrcpuk.org/mrcpuk-examinations/part-1
NICE Guidelines: https://www.nice.org.uk
British Society for Haematology: https://b-s-h.org.uk
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues



Comments